BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 22453125)

  • 1. MicroRNA expression profiling identifies miR-328 regulates cancer stem cell-like SP cells in colorectal cancer.
    Xu XT; Xu Q; Tong JL; Zhu MM; Nie F; Chen X; Xiao SD; Ran ZH
    Br J Cancer; 2012 Mar; 106(7):1320-30. PubMed ID: 22453125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploiting a novel miR-519c-HuR-ABCG2 regulatory pathway to overcome chemoresistance in colorectal cancer.
    To KK; Leung WW; Ng SS
    Exp Cell Res; 2015 Nov; 338(2):222-31. PubMed ID: 26386386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer.
    Lv Z; Wei J; You W; Wang R; Shang J; Xiong Y; Yang H; Yang X; Fu Z
    J Transl Med; 2017 Dec; 15(1):257. PubMed ID: 29258530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-372 and miR-373 enhance the stemness of colorectal cancer cells by repressing differentiation signaling pathways.
    Wang LQ; Yu P; Li B; Guo YH; Liang ZR; Zheng LL; Yang JH; Xu H; Liu S; Zheng LS; Zhou H; Qu LH
    Mol Oncol; 2018 Nov; 12(11):1949-1964. PubMed ID: 30171794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin enhances the sensitivity of hepatocellular carcinoma side population cells to doxorubicin via miR-491/ABCG2.
    Xie ZY; Liu MS; Zhang C; Cai PC; Xiao ZH; Wang FF
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30120100
    [No Abstract]   [Full Text] [Related]  

  • 6. MiR-148a suppressed cell invasion and migration via targeting WNT10b and modulating β-catenin signaling in cisplatin-resistant colorectal cancer cells.
    Shi L; Xi J; Xu X; Peng B; Zhang B
    Biomed Pharmacother; 2019 Jan; 109():902-909. PubMed ID: 30551544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiRNA-206 suppresses PGE2-induced colorectal cancer cell proliferation, migration, and invasion by targetting TM4SF1.
    Park YR; Seo SY; Kim SL; Zhu SM; Chun S; Oh JM; Lee MR; Kim SH; Kim IH; Lee SO; Lee ST; Kim SW
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30135139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-143 inhibits colorectal cancer cell proliferation by targeting MMP7.
    Yu B; Liu X; Chang H
    Minerva Med; 2017 Feb; 108(1):13-19. PubMed ID: 27827523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer resistance protein BCRP/ABCG2 regulatory microRNAs (hsa-miR-328, -519c and -520h) and their differential expression in stem-like ABCG2+ cancer cells.
    Li X; Pan YZ; Seigel GM; Hu ZH; Huang M; Yu AM
    Biochem Pharmacol; 2011 Mar; 81(6):783-92. PubMed ID: 21219875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-145 inhibits migration and invasion of glioma stem cells by targeting ABCG2.
    Shi L; Wang Z; Sun G; Wan Y; Guo J; Fu X
    Neuromolecular Med; 2014 Jun; 16(2):517-28. PubMed ID: 24777293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Side population in human non-muscle invasive bladder cancer enriches for cancer stem cells that are maintained by MAPK signalling.
    Hepburn AC; Veeratterapillay R; Williamson SC; El-Sherif A; Sahay N; Thomas HD; Mantilla A; Pickard RS; Robson CN; Heer R
    PLoS One; 2012; 7(11):e50690. PubMed ID: 23226356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CDX1-microRNA-215 axis regulates colorectal cancer stem cell differentiation.
    Jones MF; Hara T; Francis P; Li XL; Bilke S; Zhu Y; Pineda M; Subramanian M; Bodmer WF; Lal A
    Proc Natl Acad Sci U S A; 2015 Mar; 112(13):E1550-8. PubMed ID: 25775580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deregulation of the miR-222-ABCG2 regulatory module in tongue squamous cell carcinoma contributes to chemoresistance and enhanced migratory/invasive potential.
    Zhao L; Ren Y; Tang H; Wang W; He Q; Sun J; Zhou X; Wang A
    Oncotarget; 2015 Dec; 6(42):44538-50. PubMed ID: 26517090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of cancer stem cell properties, angiogenesis, and vasculogenic mimicry by miR-450a-5p/SOX2 axis in colorectal cancer.
    Chen J; Chen S; Zhuo L; Zhu Y; Zheng H
    Cell Death Dis; 2020 Mar; 11(3):173. PubMed ID: 32144236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antisense inhibition of microRNA-21 and microRNA-221 in tumor-initiating stem-like cells modulates tumorigenesis, metastasis, and chemotherapy resistance in pancreatic cancer.
    Zhao Y; Zhao L; Ischenko I; Bao Q; Schwarz B; Nieß H; Wang Y; Renner A; Mysliwietz J; Jauch KW; Nelson PJ; Ellwart JW; Bruns CJ; Camaj P
    Target Oncol; 2015 Dec; 10(4):535-48. PubMed ID: 25639539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpressing microRNA-34a overcomes ABCG2-mediated drug resistance to 5-FU in side population cells from colon cancer via suppressing DLL1.
    Xie ZY; Wang FF; Xiao ZH; Liu SF; Tang SL; Lai YL
    J Biochem; 2020 Jun; 167(6):557-564. PubMed ID: 32044957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-9 suppresses cell migration and invasion through downregulation of TM4SF1 in colorectal cancer.
    Park YR; Lee ST; Kim SL; Liu YC; Lee MR; Shin JH; Seo SY; Kim SH; Kim IH; Lee SO; Kim SW
    Int J Oncol; 2016 May; 48(5):2135-43. PubMed ID: 26983891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-133b suppresses colorectal cancer cell stemness and chemoresistance by targeting methyltransferase DOT1L.
    Lv L; Li Q; Chen S; Zhang X; Tao X; Tang X; Wang S; Che G; Yu Y; He L
    Exp Cell Res; 2019 Dec; 385(1):111597. PubMed ID: 31525340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of miR-9 promotes epithelial mesenchymal transition via regulating anoctamin-1 (ANO1) in CRC cells.
    Park YR; Lee ST; Kim SL; Zhu SM; Lee MR; Kim SH; Kim IH; Lee SO; Seo SY; Kim SW
    Cancer Genet; 2019 Feb; 231-232():22-31. PubMed ID: 30803553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GDPD5, a target of miR-195-5p, is associated with metastasis and chemoresistance in colorectal cancer.
    Feng C; Zhang L; Sun Y; Li X; Zhan L; Lou Y; Wang Y; Liu L; Zhang Y
    Biomed Pharmacother; 2018 May; 101():945-952. PubMed ID: 29635904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.